It is currently Sun Oct 04, 2015 2:35 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Dog cancer vaccine could help humans

I keep saying.."to live a dog's life!!!"
Read more : Dog cancer vaccine could help humans | Views : 970 | Replies : 0 | Forum : General Discussion

EU recommends approval for new Rebif

I'm always surprised how long it takes for this kind of approval. Hopefully regulatory agencies around the world will follow suit quickly...of course the increased incidence of flu-like symptoms with the new formula has me a bit concerned...

New Formulation of Rebif(R) Designed to Improve Tolerability and Immunogenicity Profiles

Merck Serono announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending ...
Read more : EU recommends approval for new Rebif | Views : 1551 | Replies : 2 | Forum : Drug Pipeline

UCSF Trial of Low Dose Naltrexone Still Enrolling

If you know someone in the San Francisco area with MS, let them know!
They don't have to stop any other meds.

This is the study I and other LDNers raised $25,000 to fund, since no
drug company is likely to get behind an inexpensive genric like LDN.

Read more : UCSF Trial of Low Dose Naltrexone Still Enrolling | Views : 1558 | Replies : 1 | Forum : Drug Pipeline


MediciNova Announces New Strategic Initiative

SAN DIEGO, June 26, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced that based on recent clinical successes and evaluation of market opportunities, it will focus its resources on development and commercialization of two key assets in its development pipeline, MN-221 and MN-166. MediciNova ...
Read more : MN-166 | Views : 1525 | Replies : 1 | Forum : Drug Pipeline

Men, women equally pass on genetic risk of MS

Updated Wed. Jun. 27 2007 4:00 PM ET News Staff

Men and women with multiple sclerosis equally transmit the genetic risk of the disease to their children, concludes a Canadian study published in Neurology, the medical journal of the American Academy of Neurology.

The research contradicts results of a recent study that found fathers were more likely than mothers to transmit the risk of developing MS to their children.

Researchers studied 3,088 Canadian families ...
Read more : Men, women equally pass on genetic risk of MS | Views : 1349 | Replies : 1 | Forum : General Discussion

Glial cells

New insight into the mechanism by which glial cells recognise and myelinate axons 27 June 2007

In a host of neurological diseases, including multiple sclerosis (MS) and several neuropathies, the protective covering surrounding the nerves - an insulating material called myelin - is damaged.
Scientists at the Weizmann Institute of Science have now discovered an important new line of communication between nervous system cells that is crucial to the development of myelinated nerves - ...
Read more : Glial cells | Views : 1227 | Replies : 2 | Forum : General Discussion


Yawning Saves Your Brain From Overheating
Posted by huehueteotl on June 25th, 2007

The next time you “catch a yawn” from someone across the room, you’re not copying their sleepiness, you’re participating in an ancient, hardwired ritual that might have evolved to help groups stay alert as a means of detecting danger. That’s the conclusion of University at Albany researchers Andrew C. Gallup and Gordon G. Gallup, Jr. in a study outlined in the May ...
Read more : Yawning | Views : 1911 | Replies : 5 | Forum : General Discussion


Promising prescription: $5.5B market waiting as Pipex tests 2 drugs By Andrew Dietderich

June 25, 2007

An Ann Arbor-based company that’s moving to the American Stock Exchange today plans to tap at least two drug markets that could be worth a total of $5.5 billion annually, using drugs licensed from the University of Michigan and the University of California at Los Angeles.

Two weeks ago, Pipex Pharmaceuticals Inc. (Amex: PP) received $5 million from the ...
Read more : Pipex | Views : 2086 | Replies : 10 | Forum : Drug Pipeline

UCB and Biogen Idec's Oral VLA-4 Antagonist (CDP323) Enters

UCB and Biogen Idec's Oral VLA-4 Antagonist (CDP323) Enters Phase II Development for Multiple Sclerosis

Brussels (Belgium) and Cambridge, MA (USA) - June 26, 2007- 7:00 am CET - UCB (Euronext Brussels: UCB) and Biogen Idec (NASDAQ: BIIB) today announced the initiation of a Phase II study of CDP323 - an oral VLA-4 antagonist - under development for relapsing-remitting multiple sclerosis (MS). The double-blind, randomized Phase II study commenced this week with dosing of the ...
Read more : UCB and Biogen Idec's Oral VLA-4 Antagonist (CDP323) Enters | Views : 1095 | Replies : 0 | Forum : General Discussion


i was proscribed effexor xr today for anxiety..was wondering it anyone had anything positive or negative to say about it? it does say at wipedia that you should take if you take drugs that it a cns depressant..i take avonex...anything that anybody knows about this would be great...thanks
Read more : effexor-xr// | Views : 1526 | Replies : 6 | Forum : General Discussion


Login  •  Register


Total posts 227605 • Total topics 24031 • Total members 15391

Contact us | Terms of Service